Annual Net Income
-$160.81 M
-$37.32 M-30.23%
December 31, 2023
Summary
- As of February 7, 2025, ALXO annual net profit is -$160.81 million, with the most recent change of -$37.32 million (-30.23%) on December 31, 2023.
- During the last 3 years, ALXO annual net income has fallen by -$115.06 million (-251.56%).
- ALXO annual net income is now -1071.11% below its all-time high of -$13.73 million, reached on December 31, 2018.
Performance
ALXO Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$30.71 M
+$8.69 M+22.06%
September 30, 2024
Summary
- As of February 7, 2025, ALXO quarterly net profit is -$30.71 million, with the most recent change of +$8.69 million (+22.06%) on September 30, 2024.
- Over the past year, ALXO quarterly net income has increased by +$20.28 million (+39.78%).
- ALXO quarterly net income is now -908.77% below its all-time high of -$3.04 million, reached on September 30, 2019.
Performance
ALXO Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$151.16 M
+$20.28 M+11.83%
September 30, 2024
Summary
- As of February 7, 2025, ALXO TTM net profit is -$151.16 million, with the most recent change of +$20.28 million (+11.83%) on September 30, 2024.
- Over the past year, ALXO TTM net income has dropped by -$5.12 million (-3.50%).
- ALXO TTM net income is now -3466.75% below its all-time high of -$4.24 million, reached on March 31, 2019.
Performance
ALXO TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ALXO Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -30.2% | +39.8% | -3.5% |
| 3 y3 years | -251.6% | -25.2% | -61.1% |
| 5 y5 years | -1071.1% | -116.5% | -177.5% |
ALXO Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -92.7% | at low | -25.2% | +39.8% | -81.1% | +11.8% |
| 5 y | 5-year | -735.6% | at low | -463.0% | +39.8% | -685.5% | +11.8% |
| alltime | all time | -1071.1% | at low | -908.8% | +39.8% | -3466.8% | +11.8% |
ALX Oncology Holdings Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$30.71 M(-22.1%) | -$151.16 M(-11.8%) |
| Jun 2024 | - | -$39.40 M(+10.7%) | -$171.44 M(+3.2%) |
| Mar 2024 | - | -$35.58 M(-21.8%) | -$166.20 M(+3.4%) |
| Dec 2023 | -$160.81 M(+30.2%) | -$45.47 M(-10.8%) | -$160.81 M(+10.1%) |
| Sep 2023 | - | -$50.99 M(+49.3%) | -$146.04 M(+12.0%) |
| Jun 2023 | - | -$34.16 M(+13.2%) | -$130.37 M(+1.0%) |
| Mar 2023 | - | -$30.18 M(-1.7%) | -$129.13 M(+4.6%) |
| Dec 2022 | -$123.48 M(+47.9%) | -$30.71 M(-13.1%) | -$123.48 M(+1.9%) |
| Sep 2022 | - | -$35.32 M(+7.3%) | -$121.21 M(+9.7%) |
| Jun 2022 | - | -$32.92 M(+34.2%) | -$110.46 M(+17.7%) |
| Mar 2022 | - | -$24.53 M(-13.7%) | -$93.81 M(+12.4%) |
| Dec 2021 | -$83.46 M | -$28.44 M(+15.8%) | -$83.46 M(+13.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$24.57 M(+51.0%) | -$73.80 M(+24.2%) |
| Jun 2021 | - | -$16.27 M(+14.7%) | -$59.41 M(+9.1%) |
| Mar 2021 | - | -$14.19 M(-24.4%) | -$54.47 M(+19.1%) |
| Dec 2020 | -$45.74 M(+137.7%) | -$18.77 M(+84.4%) | -$45.74 M(+31.7%) |
| Sep 2020 | - | -$10.18 M(-10.1%) | -$34.73 M(+25.9%) |
| Jun 2020 | - | -$11.33 M(+107.8%) | -$27.59 M(+34.9%) |
| Mar 2020 | - | -$5.45 M(-29.8%) | -$20.46 M(+6.3%) |
| Dec 2019 | -$19.24 M(+40.1%) | -$7.76 M(+155.1%) | -$19.24 M(+67.6%) |
| Sep 2019 | - | -$3.04 M(-27.5%) | -$11.48 M(+36.1%) |
| Jun 2019 | - | -$4.20 M(-1.0%) | -$8.44 M(+99.0%) |
| Mar 2019 | - | -$4.24 M | -$4.24 M |
| Dec 2018 | -$13.73 M | - | - |
FAQ
- What is ALX Oncology Holdings annual net profit?
- What is the all time high annual net income for ALX Oncology Holdings?
- What is ALX Oncology Holdings annual net income year-on-year change?
- What is ALX Oncology Holdings quarterly net profit?
- What is the all time high quarterly net income for ALX Oncology Holdings?
- What is ALX Oncology Holdings quarterly net income year-on-year change?
- What is ALX Oncology Holdings TTM net profit?
- What is the all time high TTM net income for ALX Oncology Holdings?
- What is ALX Oncology Holdings TTM net income year-on-year change?
What is ALX Oncology Holdings annual net profit?
The current annual net income of ALXO is -$160.81 M
What is the all time high annual net income for ALX Oncology Holdings?
ALX Oncology Holdings all-time high annual net profit is -$13.73 M
What is ALX Oncology Holdings annual net income year-on-year change?
Over the past year, ALXO annual net profit has changed by -$37.32 M (-30.23%)
What is ALX Oncology Holdings quarterly net profit?
The current quarterly net income of ALXO is -$30.71 M
What is the all time high quarterly net income for ALX Oncology Holdings?
ALX Oncology Holdings all-time high quarterly net profit is -$3.04 M
What is ALX Oncology Holdings quarterly net income year-on-year change?
Over the past year, ALXO quarterly net profit has changed by +$20.28 M (+39.78%)
What is ALX Oncology Holdings TTM net profit?
The current TTM net income of ALXO is -$151.16 M
What is the all time high TTM net income for ALX Oncology Holdings?
ALX Oncology Holdings all-time high TTM net profit is -$4.24 M
What is ALX Oncology Holdings TTM net income year-on-year change?
Over the past year, ALXO TTM net profit has changed by -$5.12 M (-3.50%)